Umbilical cord blood stem cells: What to expect

Annals of the New York Academy of Sciences

Volumn 1205, Issue , 2010, Pages 17-22

  Zhong, Xiao Yan ^a   Zhang, Bei ^a   Asadollahi, Reza ^a   Low, Shyan Huey ^a   Holzgreve, Wolfgang ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

hematopoietic stem cells; human leukocyte antigen disparity; umbilical cord blood

Indexed keywords

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CONFERENCE PAPER; ENGRAFTMENT; GENE THERAPY; GRAFT VERSUS HOST REACTION; HEMOGLOBINOPATHY; HUMAN; IN UTERO STEM CELL TRANSPLANTATION; NONHUMAN; PRENATAL DIAGNOSIS; STEM CELL; UMBILICAL CORD BLOOD; UMBILICAL CORD BLOOD STEM CELL; ADULT; ANIMAL; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOLOGY; FETUS BLOOD; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL; IMMUNOLOGIC DEFICIENCY SYNDROMES; METABOLIC DISEASES; PHYSIOLOGY; PROCEDURES; TRENDS; UTILIZATION;

ADULT; ANIMALS; CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; METABOLIC DISEASES;

EID: 77957059975     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05659.x     Document Type: Conference Paper

References (40)

1. Henningson, C.T. Jr. et al. 2003. Embryonic and adult stem cell therapy. J. Allergy Clin. Immunol. 111: S745-S753.
2. Welte, K. et al. 2010. International exchange of cord blood units: the registry aspects. BoneMarrow Transplant. 45: 825-831.
3. Halbrecht, J. 1939. Transfusion with placental blood. Lancet I: 202-204.
4. Ende, M. & N. Ende. 1972. Hematopoietic transplantation by means of fetal (cord) blood. A new method. Va. Med. Mon. (1918) 99: 276-280.
5. Broxmeyer, H.E. et al. 1989. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc. Natl. Acad. Sci. USA 86: 3828-3832.
6. Boyse, E.A. et al. 1991. Preservation of fetal and neonatal hematopoitic stem and progenitor cells of the blood. US Patent 5,004.681 issued April, 2 (assigned to Biocyte Corporation).
7. Gorin, N.C. 1986. Collection, manipulation and freezing of haemopoietic stem cells. Clin. Haematol. 15: 19-48.
8. Gluckman, E. et al. 1989. Hematopoietic reconstitution in a patient with Fanconis anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 321: 1174-1178.
9. Wagner, J.E. & E. Gluckman. 2010. Umbilical cord blood transplantation: the first 20 years. Semin. Hematol. 47: 3-12.
10. Rubinstein, P. 2009. Cord blood banking for clinical transplantation. Bone Marrow Transplant. 44: 635-642.
11. Rubinstein, P. et al. 1994. Unrelated placental blood for bone marrow reconstitution: organization of the placental blood program. Blood Cells 20: 587-596; discussion 596-600.
12. Rubinstein, P. et al. 1998. Outcomes among 562 recipients of placental-blood transplants fromunrelated donors. N. Engl. J. Med. 339: 1565-1577.
13. Surbek, D.V. et al. 1998. [Umbilical cord blood transplantation: acceptance of umbilical cord blood donation by pregnant patients]. Schweiz Med Wochenschr 128: 689-695.
14. Wang, J. et al. 2009. Unrelated donor umbilical cord blood transplantation versus unrelated donor bonemarrow transplantation in adult and pediatric patients: a meta-analysis. Leuk. Res 3709: 1-5.
15. Michel, G. et al. 2003. Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. Blood 102: 4290-4297.
16. Rocha, V. et al. 2001. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 97: 2962-2971.
17. Eapen, M. et al. 2007. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 369: 1947-1954.
18. Rocha, V. et al. 2004. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.N. Engl. J. Med. 351: 2276-2285.
19. Laughlin, M.J. et al. 2004. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N. Engl. J. Med. 351: 2265-2275.
20. Demirer, T. et al. 2008. Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors. Nat. Clin. Pract. Oncol. 5: 256-267.
21. Takami, A. et al. 2006. Reduced-intensity unrelated cord blood transplantation for treatment of metastatic renal cell carcinoma: first evidence of cord-blood-versus-solid-tumor effect. Bone Marrow Transplant. 38: 729-732.
22. Martin, P.L. et al. 2006. Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol. Blood Marrow Transplant. 12: 184-194.
23. Prasad, V.K. & J. Kurtzberg. 2009. Umbilical cord blood transplantation for non-malignant diseases. Bone Marrow Transplant. 44: 643-651.
24. Diaz de Heredia, C. et al. 2008. Unrelated cord blood transplantation for severe combined immunodeficiency and other primary immunodeficiencies. Bone Marrow Transplant. 41: 627-633.
25. Mochizuki, K. et al. 2009. Successful unrelated cord blood transplantation for chronic granulomatous disease: a case report and review of the literature. Pediatr. Transplant. 13: 384-389.
26. MacMillan, M.L. et al. 2010. Transplant outcomes in bone marrow failure syndromes and hemoglobinopathies. Semin. Hematol. 47: 37-45.
27. Fang, J. et al. 2003. Unrelated umbilical cord blood transplant for beta-thalassemia major. J. Trop. Pediatr. 49: 71-73.
28. Neudorf, S.M. et al. 1995.Graft failure after anumbilical cord blood transplant in a patient with severe aplastic anemia. Blood 85: 2991-2992.
29. Yoshimi, A. et al. 2008.Unrelated cord blood transplantation for severe aplastic anemia. Biol. BloodMarrowTransplant. 14: 1057-1063.
30. Ohga, S. et al. 2006. Unrelated donor cord blood transplantation for childhood severe aplastic anemia after a modified conditioning. Pediatr. Transplant. 10: 497-500.
31. Barker, J.N. et al. 2005. Transplantation of 2 partially HLAmatched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105: 1343-1347.
32. Brunstein, C.G. et al. 2007. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 110: 3064-3070.
33. Brunstein, C.G. et al. 2009. Intra-BM injection to enhance engraftment aftermyeloablative umbilical cord blood transplantationwith two partiallyHLA-matched units.BoneMarrow Transplant. 43: 935-940.
34. Kelly, S.S. et al. 2009. ex vivo expansion of cord blood. Bone Marrow Transplant. 44: 673-681.
35. Escalon, M.P. & K.V. Komanduri. 2010. Cord blood transplantation: evolving strategies to improve engraftment and immune reconstitution. Curr. Opin. Oncol. 22: 122-129.
36. Manegold, G. et al. 2008. Cesarean section due to fetal distress increases the number of stem cells in umbilical cord blood. Transfusion 48: 871-876.
37. Young, A.J. et al. 2003. Engraftment of human cord blood-derived stem cells in preimmune ovine fetuses after ultrasound-guided in utero transplantation. Am. J. Obstet. Gynecol. 189: 698-701.
38. Troeger, C. et al. 2007. in utero haematopoietic stem cell transplantation. Experiences in mice, sheep and humans. Swiss Med. Wkly. 137(Suppl 155): 14S-19S.
39. Lee, H. et al. 2010. Human Umbilical Cord Blood-Derived Mesenchymal StemCells Improve Neurological Abnormalities of Niemann-Pick Type CMouse byModulation of Neuroinflammatory Condition. J. Vet. Med. Sci. May 13.
40. Turner, C.G. & D.O. Fauza. 2009. Fetal tissue engineering. Clin. Perinatol. 36: 473-488.